Becker, Matthew C <br/><br/>
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.  [electronic resource] 

 -  American heart journal  Apr 2009 
 - 606-12 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2008.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Arthritis--drug therapy<br/>Cardiovascular Diseases--epidemiology<br/>Celecoxib<br/>Cyclooxygenase Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Follow-Up Studies<br/>Humans<br/>Ibuprofen--administration & dosage<br/>Middle Aged<br/>Naproxen--administration & dosage<br/>Prospective Studies<br/>Pyrazoles--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome